MAPT and Huntington disease: Other markers of axonal and glial degeneration in HD continue to be reported, leading to a profile of glial‐related inflammatory CSF biomarkers (eg, YKL‐40, GFAP) as well as cytoskeletal and myelin markers of neurodegeneration (eg, NfL, tau).